Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus
- PMID: 19909942
- PMCID: PMC4507370
- DOI: 10.1016/j.ajo.2009.08.030
Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus
Abstract
Purpose: To describe the characteristics and course of late varicella-zoster virus (VZV) dendriform keratitis in patients with histories of herpes zoster ophthalmicus (HZO); to describe responses of corneal lesions to antiviral treatment; and to investigate risk factors for recurrence.
Design: Retrospective case series.
Methods: Included were patients known to have 1 or more episodes of dendriform lesions beginning at least 2 weeks after HZO in 2 academic practices. Epithelial lesions were evaluated for the presence of VZV DNA by a polymerase chain reaction assay. Demographic, medical, and ophthalmic data were collected for each episode. Responses to treatment with antiviral medications were evaluated. Cumulative risk of recurrence was determined using Kaplan-Meier analysis; potential risk factors for recurrence (age, systemic disease, lesion characteristics, corticosteroids) were evaluated using univariate Cox proportional hazard models.
Results: We identified 20 patients (14 women; median age, 65 years) who met inclusion criteria. Dendriform lesions were pleomorphic with thickened, opaque epithelium. Seven patients had systemic diseases characterized by altered immune function. VZV DNA was identified in 15 of 16 cases tested, and all lesions responded to antiviral therapy. The 1-year incidence of first recurrence was 95.8 lesions per 100 person-years of follow-up. Patients had multiple recurrences, but risk of recurrence appeared to decrease over time. No statistically significant risk factors for recurrence were identified.
Conclusions: Late dendriform lesions associated with HZO are foci of productive VZV infection. Lesions can be treated effectively with topical or systemic antiviral agents. Patients can have multiple recurrences of dendriform lesions despite treatment.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no interests in the products or techniques described in this report or in competing techniques. The authors have no other conflicts of interest with any other aspects of this study.
Figures


Similar articles
-
Chronic recurrent varicella-zoster virus keratitis confirmed by polymerase chain reaction testing.Am J Ophthalmol. 2005 Jun;139(6):1135-6. doi: 10.1016/j.ajo.2004.12.014. Am J Ophthalmol. 2005. PMID: 15953460
-
Chronic recurrent varicella-zoster virus keratitis confirmed by polymerase chain reaction testing.Am J Ophthalmol. 2006 Apr;141(4):782; author reply 782. doi: 10.1016/j.ajo.2005.12.023. Am J Ophthalmol. 2006. PMID: 16564841 No abstract available.
-
Two cases of varicella zoster virus keratitis with atypical extensive pseudodendrites.Jpn J Ophthalmol. 2009 Sep;53(5):548-9. doi: 10.1007/s10384-009-0710-7. Epub 2009 Oct 22. Jpn J Ophthalmol. 2009. PMID: 19847615 No abstract available.
-
Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis.Ocul Immunol Inflamm. 2018;26(2):171-177. doi: 10.1080/09273948.2017.1383447. Epub 2017 Oct 12. Ocul Immunol Inflamm. 2018. PMID: 29023181 Review.
-
Varicella zoster virus ocular disease.Int Ophthalmol Clin. 1998 Fall;38(4):149-60. doi: 10.1097/00004397-199803840-00014. Int Ophthalmol Clin. 1998. PMID: 10081731 Review.
Cited by
-
Steroids in the Management of Infectious Keratitis.Cornea. 2023 Nov 1;42(11):1333-1339. doi: 10.1097/ICO.0000000000003340. Epub 2023 Jul 4. Cornea. 2023. PMID: 38112645 Free PMC article. Review.
-
Results of long-term antiviral prophylactic treatment on the course of herpes zoster ophthalmicus with ocular involvement: A case series in a tertiary uveitis clinic - A 1-year follow-up.Taiwan J Ophthalmol. 2023 Apr 28;15(1):114-119. doi: 10.4103/tjo.TJO-D-23-00001. eCollection 2025 Jan-Mar. Taiwan J Ophthalmol. 2023. PMID: 40213291 Free PMC article.
-
Current Practice Patterns and Opinions on the Management of Recent-Onset or Chronic Herpes Zoster Ophthalmicus of Zoster Eye Disease Study Investigators.Cornea. 2019 Jan;38(1):13-17. doi: 10.1097/ICO.0000000000001732. Cornea. 2019. PMID: 30157049 Free PMC article. Clinical Trial.
-
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD002898. doi: 10.1002/14651858.CD002898.pub5. Cochrane Database Syst Rev. 2015. PMID: 25879115 Free PMC article.
-
Pathobiology and treatment of viral keratitis.Exp Eye Res. 2021 Apr;205:108483. doi: 10.1016/j.exer.2021.108483. Epub 2021 Feb 6. Exp Eye Res. 2021. PMID: 33556334 Free PMC article. Review.
References
-
- Marsh RJ, Fraunfelder FT, McGill JI. Herpetic corneal epithelial disease. Arch Ophthalmol. 1976;94:1899–1902. - PubMed
-
- Engstrom RE, Holland GN. Chronic herpes zoster virus keratitis associated with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;105:556–558. - PubMed
-
- Chern KC, Conrad D, Holland GN, Holsclaw DS, Schwartz LK, Margolis TP. Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1998;116:1011–1017. - PubMed
-
- Pavan-Langston D, Yamamoto S, Dunkel EC. Delayed herpes zoster pseudodendrites. Polymerase chain reaction detection of viral DNA and a role for antiviral therapy. Arch Ophthalmol. 1995;113:1381–1385. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous